L-ASPARAGINASE - THERAPEUTIC AND TOXIC EFFECTS IN PATIENTS WITH NEOPLASTIC DISEASE

[1] EFFECTS OF L-ASPARAGINE AND RELATED COMPOUNDS ON HEPATIC FATTY INFILTRATION AND NECROSIS INDUCED BY ETHIONINE AND CARBON TETRACHLORIDE [J]. BIOCHEMICAL PHARMACOLOGY, 1967, 16 (06) : 1091 - &

[2] BETTIGOLE R E, 1969, Clinical Research, V17, P399

[3] EVIDENCE THAT L-ASPARAGINASE ACTIVITY OF GUINEA PIG SERUM IS RESPONSIBLE FOR ITS ANTILYMPHOMA EFFECTS [J]. NATURE, 1961, 191 (479) : 1114 - &

[4] STUDIES ON MECHANISM OF TUMOR INHIBITION BY L-ASPARAGINASE - EFFECTS OF ENZYME ON ASPARAGINE LEVELS IN BLOOD NORMAL TISSUES AND 6C3HED LYMPHOMAS OF MICE - DIFFERENCES IN ASPARAGINE FORMATION AND UTILIZATION IN ASPARAGINASE-SENSITIVE AND -RESISTANT LYMPHOMA CELLS [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1968, 127 (06) : 1055 - &

[5] BURCHENAL JH, 1968, 12 C INT SOC HEM

[6] CANELLOS GP, 1969, CANCER CHEMOTH REP 1, V53, P67

[7] CAPIZZI RL, 1969, P AM ASSOC CANC RES, V10, P12

[8] COONEY DA, 1968, P AM ASSOC CANC RES, V9, P15

[9] FARBER E, 1950, P SOC EXP BIOL MED, V74, P838, DOI 10.3181/00379727-74-18062

[10] GRALNICK HR, 1969, P AM ASSOC CANC RES, V10, P32

[1] EFFECTS OF L-ASPARAGINE AND RELATED COMPOUNDS ON HEPATIC FATTY INFILTRATION AND NECROSIS INDUCED BY ETHIONINE AND CARBON TETRACHLORIDE [J]. BIOCHEMICAL PHARMACOLOGY, 1967, 16 (06) : 1091 - &

[2] BETTIGOLE R E, 1969, Clinical Research, V17, P399

[3] EVIDENCE THAT L-ASPARAGINASE ACTIVITY OF GUINEA PIG SERUM IS RESPONSIBLE FOR ITS ANTILYMPHOMA EFFECTS [J]. NATURE, 1961, 191 (479) : 1114 - &

[4] STUDIES ON MECHANISM OF TUMOR INHIBITION BY L-ASPARAGINASE - EFFECTS OF ENZYME ON ASPARAGINE LEVELS IN BLOOD NORMAL TISSUES AND 6C3HED LYMPHOMAS OF MICE - DIFFERENCES IN ASPARAGINE FORMATION AND UTILIZATION IN ASPARAGINASE-SENSITIVE AND -RESISTANT LYMPHOMA CELLS [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1968, 127 (06) : 1055 - &

[5] BURCHENAL JH, 1968, 12 C INT SOC HEM

[6] CANELLOS GP, 1969, CANCER CHEMOTH REP 1, V53, P67

[7] CAPIZZI RL, 1969, P AM ASSOC CANC RES, V10, P12

[8] COONEY DA, 1968, P AM ASSOC CANC RES, V9, P15

[9] FARBER E, 1950, P SOC EXP BIOL MED, V74, P838, DOI 10.3181/00379727-74-18062

[10] GRALNICK HR, 1969, P AM ASSOC CANC RES, V10, P32